Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Engage Grants Program

Université Laval

$24,975.00

Requirements for transitioning a new robotic needle-guide from biopsy to therapy applications

EF 2015-16

Résumé
Prostate cancer is the most common cancer in men in industrialized countries. With the tremendous advanced in imaging, in particular magnetic resonance imaging (MRI), multi-parametric MRI is now enabling more accurate localization of cancerous regions within the prostate and opens-up new treatment possibilities. One of them is prostate focal therapy, which consist in the treatment of only the cancer proven zone(s) within the prostate. This approach is expected to lead to reduce toxicity and better quality of life. The present proposal is related to a new biomedical technology enabling accurate, real-time MRI-guided biopsy taking using a robotic needle guide developed by Polymer Robotics from Sherbrooke, Quebec. This device is unique and the propose research intends to evaluate the capacity of the device to also perform needle-based therapy such as (but not limited to) brachytherapy, cryotherapy and many others. There is currently no such robotic device on the market that can perform both diagnostic procedures (biopsy) and therapy procedures under real-time MRI.
Programme
Engage Grants Program
Bénéficiaire
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data

Tel que publié

Application id
486072-2015
Name nom
Beaulieu, Luc
Department département
Physique, génie physique et optique
Organization id
51
Institution établissement
Université Laval
Province en
Québec
Province fr
Québec
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2015
Competition year année de concours
2015
Award amount
24975
Program id
EGP
Program name en
Engage Grants Program
Program name fr
Programme de subventions d'engagement partenariat
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
1552
Committee name en
Quebec Internal Decision Committee
Committee name fr
Comité de décision interne pour le Québec
Area of application code
518
Area of application group en
Manufacturing processes and products
Area of application group fr
Procédés et produits industriels
Area of application en
Medical equipment and apparatus
Area of application fr
Appareils et instruments médicaux
Research subject code
1901
Research subject group en
Biomedical engineering
Research subject group fr
Génie biomédical
Research subject en
Biomedical technology
Research subject fr
Technologie biomédicale
Partie
1
Nb partie
1
Application title
Requirements for transitioning a new robotic needle-guide from biopsy to therapy applications
Keyword
NSERC
Application summary
Prostate cancer is the most common cancer in men in industrialized countries. With the tremendous advanced in imaging, in particular magnetic resonance imaging (MRI), multi-parametric MRI is now enabling more accurate localization of cancerous regions within the prostate and opens-up new treatment possibilities. One of them is prostate focal therapy, which consist in the treatment of only the cancer proven zone(s) within the prostate. This approach is expected to lead to reduce toxicity and better quality of life. The present proposal is related to a new biomedical technology enabling accurate, real-time MRI-guided biopsy taking using a robotic needle guide developed by Polymer Robotics from Sherbrooke, Quebec. This device is unique and the propose research intends to evaluate the capacity of the device to also perform needle-based therapy such as (but not limited to) brachytherapy, cryotherapy and many others. There is currently no such robotic device on the market that can perform both diagnostic procedures (biopsy) and therapy procedures under real-time MRI.